Heron (HRTX) Q2 2026 Earnings Call Transcript
Patent setback forces guidance withdrawal as acute care revenue surges 44% year over year.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Forget the Earnings Miss: Exxon's Underlying Numbers Tell a Different Story
The fundamentals remain remarkably strong.
Kaiser Permanente notches 4.6% Q2 operating margin, $5.3B net income
The country's largest nonprofit health system outlined a 10.9% year-over-year increase in operating revenues for the quarter ended June 30.
N-able (NABL) Q2 2026 Earnings Call Transcript
Data protection gains offset by pricing pressure in endpoint markets.
Accendra Health (ACH) Q2 2026 Earnings Call Transcript
Collection rate headwinds and delayed cost cuts weighed on Q2 results.
